FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040902100> ?p ?o ?g. }

• W2040902100 endingPage "998" @default.
• W2040902100 startingPage "994" @default.
• W2040902100 abstract "Cardiovascular disease is the most common cause of death among renal transplant recipients (RTRs). Impaired fibrinolytic capacity caused by an increase in plasminogen activator inhibitor type 1 (PAI-1) levels is involved in the onset of atherosclerosis and thrombotic complications. Long-term steroid treatment may induce arterial hypertension and metabolic and prothrombotic changes (including up-regulation of PAI-1 synthesis), which increase the cardiovascular risk. We evaluated plasma fibrinolytic behavior in two groups of RTRs treated with different immunosuppressive regimens.Twenty-seven RTRs were randomized to receive long-term (17 patients) or perioperative short-term (10 patients) steroids in addition to immunosuppression with cyclosporine A plus everolimus (Certican; Novartis, Basel, Switzerland) (7 patients) or FK506 plus mycophenolate mofetil (20 patients). In each patient, fibrinolytic capacity was studied with the 20-min venous occlusion test 1 and 6 months after transplantation. The following were assayed: euglobulin lysis time, tissue-type plasminogen activator antigen, and PAI-1 antigen and activity.One month after transplantation, a severe impairment of fibrinolytic capacity, mainly caused by an increase in PAI-1 antigen and activity levels, was seen in patients with and without steroid treatment. Six months after transplantation, an improvement in fibrinolytic potential as the result of a decrease in PAI-1 levels was observed only in patients without steroid therapy. None of the steroid-treated patients demonstrated PAI-1 values correlating with body mass index, blood pressure, and metabolic parameters, thus confirming the effect of exogenous factors on PAI-1 expression. Moreover, all patients revealed a slight impairment of stimulated endothelial tissue-type plasminogen activator release, regardless of any steroid treatment, which was probably attributable to calcineurin inhibitor-induced endothelial dysfunction.Our study suggests that steroid-free immunosuppression is associated with a better fibrinolytic capacity in RTRs. This finding may contribute toward reducing the risk of cardiovascular events." @default.
• W2040902100 created "2016-06-24" @default.
• W2040902100 creator A5019182161 @default.
• W2040902100 creator A5019823502 @default.
• W2040902100 creator A5020528802 @default.
• W2040902100 creator A5025538499 @default.
• W2040902100 creator A5026279836 @default.
• W2040902100 creator A5046561459 @default.
• W2040902100 creator A5047550910 @default.
• W2040902100 creator A5071745188 @default.
• W2040902100 date "2003-04-15" @default.
• W2040902100 modified "2023-09-27" @default.
• W2040902100 title "Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy" @default.
• W2040902100 cites W15186908 @default.
• W2040902100 cites W175652702 @default.
• W2040902100 cites W1965584732 @default.
• W2040902100 cites W1969230739 @default.
• W2040902100 cites W1973771885 @default.
• W2040902100 cites W1979331523 @default.
• W2040902100 cites W1985571864 @default.
• W2040902100 cites W1992255677 @default.
• W2040902100 cites W1996147982 @default.
• W2040902100 cites W2009376985 @default.
• W2040902100 cites W2012464351 @default.
• W2040902100 cites W2023287941 @default.
• W2040902100 cites W2025589168 @default.
• W2040902100 cites W2037857651 @default.
• W2040902100 cites W2037897878 @default.
• W2040902100 cites W2039844911 @default.
• W2040902100 cites W2049439385 @default.
• W2040902100 cites W2052803306 @default.
• W2040902100 cites W2054332819 @default.
• W2040902100 cites W2062208260 @default.
• W2040902100 cites W2082807624 @default.
• W2040902100 cites W2093699014 @default.
• W2040902100 cites W2117931787 @default.
• W2040902100 cites W2125879298 @default.
• W2040902100 cites W2140578759 @default.
• W2040902100 cites W2144352269 @default.
• W2040902100 cites W2162614265 @default.
• W2040902100 cites W2331577680 @default.
• W2040902100 cites W2332741537 @default.
• W2040902100 cites W2341503417 @default.
• W2040902100 cites W2402440509 @default.
• W2040902100 cites W2423461387 @default.
• W2040902100 cites W292647304 @default.
• W2040902100 cites W4245010354 @default.
• W2040902100 doi "https://doi.org/10.1097/01.tp.0000058544.71993.e6" @default.
• W2040902100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12698086" @default.
• W2040902100 hasPublicationYear "2003" @default.
• W2040902100 type Work @default.
• W2040902100 sameAs 2040902100 @default.
• W2040902100 citedByCount "31" @default.
• W2040902100 countsByYear W20409021002013 @default.
• W2040902100 countsByYear W20409021002015 @default.
• W2040902100 countsByYear W20409021002016 @default.
• W2040902100 countsByYear W20409021002017 @default.
• W2040902100 countsByYear W20409021002018 @default.
• W2040902100 countsByYear W20409021002021 @default.
• W2040902100 crossrefType "journal-article" @default.
• W2040902100 hasAuthorship W2040902100A5019182161 @default.
• W2040902100 hasAuthorship W2040902100A5019823502 @default.
• W2040902100 hasAuthorship W2040902100A5020528802 @default.
• W2040902100 hasAuthorship W2040902100A5025538499 @default.
• W2040902100 hasAuthorship W2040902100A5026279836 @default.
• W2040902100 hasAuthorship W2040902100A5046561459 @default.
• W2040902100 hasAuthorship W2040902100A5047550910 @default.
• W2040902100 hasAuthorship W2040902100A5071745188 @default.
• W2040902100 hasBestOaLocation W20409021001 @default.
• W2040902100 hasConcept C126322002 @default.
• W2040902100 hasConcept C134018914 @default.
• W2040902100 hasConcept C203014093 @default.
• W2040902100 hasConcept C2776825266 @default.
• W2040902100 hasConcept C2779679481 @default.
• W2040902100 hasConcept C2780252810 @default.
• W2040902100 hasConcept C2780675426 @default.
• W2040902100 hasConcept C2911091166 @default.
• W2040902100 hasConcept C71924100 @default.
• W2040902100 hasConcept C90924648 @default.
• W2040902100 hasConceptScore W2040902100C126322002 @default.
• W2040902100 hasConceptScore W2040902100C134018914 @default.
• W2040902100 hasConceptScore W2040902100C203014093 @default.
• W2040902100 hasConceptScore W2040902100C2776825266 @default.
• W2040902100 hasConceptScore W2040902100C2779679481 @default.
• W2040902100 hasConceptScore W2040902100C2780252810 @default.
• W2040902100 hasConceptScore W2040902100C2780675426 @default.
• W2040902100 hasConceptScore W2040902100C2911091166 @default.
• W2040902100 hasConceptScore W2040902100C71924100 @default.
• W2040902100 hasConceptScore W2040902100C90924648 @default.
• W2040902100 hasIssue "7" @default.
• W2040902100 hasLocation W20409021001 @default.
• W2040902100 hasLocation W20409021002 @default.
• W2040902100 hasLocation W20409021003 @default.
• W2040902100 hasOpenAccess W2040902100 @default.
• W2040902100 hasPrimaryLocation W20409021001 @default.
• W2040902100 hasRelatedWork W1781372697 @default.
• W2040902100 hasRelatedWork W2078057762 @default.
• W2040902100 hasRelatedWork W2087359835 @default.

• next